PTCB Guide to Insulins.

What gets tested on the PTCB exam?

An estimated 40.1 million people in the United States have diabetes – either diagnosed or undiagnosed diabetes. That’s approximately 12% of the population—about 1 in 8 people. Given its prevalence, it’s essential for pharmacy technicians to understand diabetes medications, including insulin therapies.

For the PTCB exam, pharmacy technicians are required to learn the following:

• Classification and identification of insulins – including rapid-acting (lispro, aspart), short-acting (regular), intermediate-acting (NPH), and long-acting (glargine, detemir, degludec).
• To recognize common brand and generic names.
• To understand onset/peak/duration patterns (at a general level).
• To identify which insulins are used for mealtime (bolus) coverage versus basal control.
• Pharmacy technicians should also know common concentration differences (e.g. U-100 vs. U-500), and that insulin is measured in units, not milligrams.

In addition, the PTCB exam may test proper storage and handling (refrigeration before opening, room temperature stability after first use), device types (vials, pens), and key safety considerations such as avoiding product mix-ups (e.g. look-alike/sound-alike names) and understanding that most insulins should not be interchanged without pharmacist authorization.

The focus is on safe dispensing, accurate product selection, and recognizing high-alert medication precautions.

What Technicians are Not Required to Learn.

Pharmacy technicians are not expected to study or prepare for the following topics:

• Detailed insulin dosing calculations for individual patients.
• How to design basal–bolus regimens, carbohydrate counting adjustments, correction factors, or how to titrate insulin based on blood glucose readings — those are pharmacist or prescriber responsibilities.
• Technicians are also not expected to manage complex endocrine physiology, interpret HbA1c trends clinically, or make therapeutic substitution decisions between different insulin products.

Remember, the PTCB exam focuses on safe identification, handling, and dispensing rather than individualized clinical management of diabetes. Keep this focus in mind when studying insulins (and generally, other topics for the Medications knowledge domain).

PTCB Basics – Diabetes Types and Insulin Requirements.

First, it’s important to know the differences between the two main types of diabetes, and where insulin is used in the management of both:

• Type 1 diabetes is an autoimmune condition in which β-cells of the pancreas are destroyed, resulting in an absolute deficiency of insulin. Patients therefore require lifelong insulin therapy for survival.
• Type 2 diabetes, in contrast, is characterized primarily by insulin resistance combined with a relative insulin deficiency over time; the pancreas still produces insulin, especially early in the disease, but the body does not respond to it effectively.

Pharmacy technicians must recognize that insulin is required in all patients with type 1 diabetes, as they cannot produce their own insulin. In type 2 diabetes, insulin is typically introduced when oral or non-insulin injectable medicines are insufficient to achieve glycemic control (control of blood sugar levels), during periods of acute illness, or in advanced disease.

How are insulins administered – and what are Units?

Insulin is administered via the subcutaneous route (under the skin) because it is a protein that would otherwise be broken down by acid in the stomach if taken by other routes of administration.

Insulin should also be stored at room temperature before opening to maintain stability and potency while avoiding cold-induced degradation or crystallization that often occur in the refrigerator.

It is commonly administered using:

• Insulin pens
• Vials with syringes
• Insulin pumps

Injections are typically made in the abdomen, thigh, or upper arm. In hospital settings, insulin may also be given intravenously (e.g. regular insulin in DKA), but this is not used for routine outpatient management.

Over the course of this guide, we have referred to units of insulin. By “Units”, we are describing a standardized measure of insulin’s biological activity, not its weight in milligrams. Most insulin in the US is U-100, meaning 100 Units per milliliter, though more concentrated forms also exist, such as:

• U-200
• U-300
• U-500

Because insulin is dosed in Units, accurate product selection and concentration verification are essential to prevent medication error.

What are Basal Insulins?

In insulin therapy, basal insulins provide a steady background level of insulin to control blood glucose between meals and overnight. By basal insulin, we mean a long-acting insulin that provides a steady, background level of insulin to help maintain blood glucose between meals and overnight. The most commonly used basal insulins include:

• insulin glargine
• insulin detemir
• insulin degludec

These insulins have long or ultra-long durations of action with minimal peaks.

In contrast, rapid-acting insulins (lispro, aspart, glulisine) and short-acting insulin (regular insulin) are not basal, as they are designed to cover mealtime glucose spikes and have a much faster onset and shorter duration of action. Intermediate-acting insulin, such as NPH, can serve a basal role but is less predictable due to its pronounced peak and shorter duration compared with modern long-acting options.

Pharmacy technicians are required to know which insulins are basal versus bolus for safe dispensing and patient counseling.

Insulin Medicines Tested on the PTCB Exam.

Below is a summary of all key insulins to know for the PTCB exam.

Insulins are typically classified by how long they act i.e. whether they are rapid-acting, intermediate-acting or long-acting. We have included key examples, brand and generic names, as well as more details on duration – such as onset of effect, when the insulin effect peaks, as well as overall duration of effect.

Here are four excellent mnemonics to help you remember which insulins are rapid-acting and which are long-acting:

• There is no “lag” with rapid-acting insulins. By no lag, we mean no delay – they act rapidly. LAG – Lispro, Aspart, Glulisine.
• Glargine → think “G for Gone all day” (provides steady insulin coverage 24 hours).
• Detemir → sounds like “Determine to last”, reminding you it has a long, stable effect.
• Think: “Degludec = decades = ultra-long acting”.

PTCB Exam-Style Sample Questions.

Below you can find five sample PTCB exam questions on the topic of insulins.

These five questions reflect the type of questions that get tested about insulins on the exam – both the style and difficulty. As always, have a go at the questions yourself before comparing your answers with the explanations (in the section below).

Question 1.

Which of the following insulins is rapid-acting?

a. regular insulin

b. insulin lispro

c. NPH insulin

d. insulin glargine

Question 2.

Which of the following statements about insulin degludec is correct?

a. it is a rapid-acting insulin used at mealtimes

b. it is an ultra-long-acting basal insulin

c. it is intermediate-acting and often combined with short-acting insulin

d. it is only used intravenously in hospitals

Question 3.

A pharmacy technician should counsel patients that insulin:

a. can be taken orally

b. should be stored at room temperature before opening

c. is dosed in milligrams

d. is not affected by temperature

Question 4.

NPH insulin is classified as:

a. rapid-acting

b. short-acting

c. intermediate-acting

d. long-acting

Question 5.

Which of the following is the recommended route and typical injection sites for routine subcutaneous insulin administration?

a. Oral; stomach and thighs

b. Intravenous; forearm or hand

c. Intramuscular; buttocks or deltoid

d. Subcutaneous; abdomen, thigh, or upper arm

Answer Explanations.

Answer to Question 1 – b. Insulin lispro

Insulin lispro is an example of a rapid-acting insulin. Other rapid-acting insulins include insulin aspart and insulin glulisine.

Answer to Question 2 – b. It is an ultra-long-acting basal insulin

Ultra-long-acting basal insulin, like degludec, provides a steady, near-constant insulin level for over 24 hours to control blood glucose between meals and overnight.

Answer to Question 3 – b. Should be stored at room temperature before opening

Insulin should be stored at room temperature before opening to maintain stability and potency while avoiding cold-induced degradation or crystallization that can occur in the refrigerator.

Answer to Question 4 – c. Intermediate-acting

NPH insulin is classified as intermediate-acting, meaning it provides a slower onset and longer duration of action than short-acting insulins, helping to control blood glucose between meals and overnight.

Answer to Question 5 – d. d. Subcutaneous; abdomen, thigh, or upper arm

Insulin is usually given subcutaneously to avoid degradation in the GI tract, with common injection sites including the abdomen, thighs, and upper arms, which allow for predictable absorption.

Insulin Cheat Sheet – PTCB Key Facts.

Over the course of this week’s study guide, we learned:

Insulin Types by Action

• Rapid-acting: Lispro, Aspart, Glulisine
  • Onset: 10–30 min
  • Peak: 30 min–3 hr
  • Duration: 3–5 hr
  • Used for mealtime coverage (bolus)
• Short-acting: Regular insulin
  • Onset: 30 min–1 hr
  • Peak: 2–5 hr
  • Duration: 5–8 hr
  • Covers mealtime glucose spikes
• Intermediate-acting: NPH
  • Onset: 1–2 hr
  • Peak: 4–12 hr
  • Duration: 12–18 hr
  • Can act as basal insulin, less predictable
• Long-acting: Glargine, Detemir
  • Onset: 1–2 hr
  • No significant peak
  • Duration: 20–24 hr
  • Provides steady basal coverage
• Ultra-long-acting: Degludec
  • Onset: 1 hr
  • Duration: up to 42 hr
  • Very stable basal insulin

Basal vs Bolus

• Basal: long or ultra-long acting, provides background insulin (glargine, detemir, degludec)
• Bolus/Mealtime: rapid or short-acting, used to cover meals (lispro, aspart, glulisine, regular)
• Intermediate (NPH): can be basal but has peak; less preferred for steady coverage

Routes and Administration

• Typically subcutaneous (abdomen, thigh, upper arm)
• Can be IV only for short-acting insulin in hospital emergencies
• Administered with vials/syringes, pens, or pumps
• Rotation of injection sites helps prevent lipodystrophy

Units and Concentration

• Most insulin is U-100 (100 units/mL)
• Other concentrations: U-200, U-300, U-500
• Dose is measured in Units, not milligrams

Storage

• Store unopened insulin in the refrigerator
• Once opened, most can be kept at room temperature for a limited period (check product-specific guidelines)
• Protect from heat, freezing, and direct sunlight

Clinical Use

• Type 1 diabetes: all patients require insulin
• Type 2 diabetes: used when oral/non-insulin therapy insufficient or during acute illness (for more information on the first-line drug for type 2 diabetes, check out our PTCB guide to metformin).
• Basal insulins maintain blood glucose between meals; bolus insulins control postprandial spikes (post-meal).

Safety

• Insulin is a high-alert medication
• Check concentration, type, and expiration before dispensing
• Counsel patients on proper administration, storage, and hypoglycemia recognition

Key Mnemonics

• Basal: Glargine, Detemir, Degludec = “steady background”
• Ultra-long: Degludec = “decades = ultra-long”
• Rapid: Lispro, Aspart, Glulisine – no ‘lag’ period, they act rapidly.
• Glargine → think “G for Gone all day” (provides steady insulin coverage 24 hours).
• Detemir → sounds like “Determine to last”, reminding you it has a long, stable effect.

Hope you found this week’s PTCB guide to insulins helpful! Check back to our blog soon for more exclusive content to help you prepare for your pharmacy technician exam.

Master this topic and every other topic of the PTCB exam by becoming a full member of our self-paced online program.